rs2229265

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004525.3(LRP2):​c.10503G>A​(p.Gln3501Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 1,613,744 control chromosomes in the GnomAD database, including 206,212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 16472 hom., cov: 32)
Exomes 𝑓: 0.50 ( 189740 hom. )

Consequence

LRP2
NM_004525.3 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.74

Publications

16 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • congenital heart disease
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004525.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-169176479-C-T is Benign according to our data. Variant chr2-169176479-C-T is described in ClinVar as Benign. ClinVar VariationId is 129490.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.74 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.10503G>Ap.Gln3501Gln
synonymous
Exon 54 of 79NP_004516.2P98164

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.10503G>Ap.Gln3501Gln
synonymous
Exon 54 of 79ENSP00000496870.1P98164
LRP2
ENST00000649153.1
n.1401G>A
non_coding_transcript_exon
Exon 6 of 30ENSP00000497617.1A0A3B3IT64

Frequencies

GnomAD3 genomes
AF:
0.451
AC:
68471
AN:
151888
Hom.:
16459
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.320
Gnomad AMI
AF:
0.448
Gnomad AMR
AF:
0.602
Gnomad ASJ
AF:
0.452
Gnomad EAS
AF:
0.104
Gnomad SAS
AF:
0.479
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.491
Gnomad NFE
AF:
0.519
Gnomad OTH
AF:
0.467
GnomAD2 exomes
AF:
0.482
AC:
121013
AN:
251286
AF XY:
0.482
show subpopulations
Gnomad AFR exome
AF:
0.320
Gnomad AMR exome
AF:
0.666
Gnomad ASJ exome
AF:
0.459
Gnomad EAS exome
AF:
0.0978
Gnomad FIN exome
AF:
0.455
Gnomad NFE exome
AF:
0.515
Gnomad OTH exome
AF:
0.499
GnomAD4 exome
AF:
0.503
AC:
734999
AN:
1461738
Hom.:
189740
Cov.:
53
AF XY:
0.502
AC XY:
365166
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.312
AC:
10446
AN:
33480
American (AMR)
AF:
0.658
AC:
29444
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.457
AC:
11932
AN:
26134
East Asian (EAS)
AF:
0.114
AC:
4508
AN:
39696
South Asian (SAS)
AF:
0.490
AC:
42291
AN:
86256
European-Finnish (FIN)
AF:
0.454
AC:
24242
AN:
53414
Middle Eastern (MID)
AF:
0.501
AC:
2890
AN:
5768
European-Non Finnish (NFE)
AF:
0.522
AC:
580537
AN:
1111884
Other (OTH)
AF:
0.475
AC:
28709
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
20959
41917
62876
83834
104793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16520
33040
49560
66080
82600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.451
AC:
68522
AN:
152006
Hom.:
16472
Cov.:
32
AF XY:
0.450
AC XY:
33439
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.320
AC:
13271
AN:
41432
American (AMR)
AF:
0.602
AC:
9212
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.452
AC:
1568
AN:
3470
East Asian (EAS)
AF:
0.104
AC:
535
AN:
5168
South Asian (SAS)
AF:
0.480
AC:
2312
AN:
4816
European-Finnish (FIN)
AF:
0.454
AC:
4791
AN:
10548
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.519
AC:
35293
AN:
67966
Other (OTH)
AF:
0.467
AC:
987
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1845
3690
5536
7381
9226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.481
Hom.:
35473
Bravo
AF:
0.454
Asia WGS
AF:
0.346
AC:
1203
AN:
3478
EpiCase
AF:
0.520
EpiControl
AF:
0.529

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
not provided (3)
-
-
2
Donnai-Barrow syndrome (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.032
DANN
Benign
0.18
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2229265;
hg19: chr2-170032989;
COSMIC: COSV55546414;
COSMIC: COSV55546414;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.